Lopinavir/Ritonavir
- Generic Name
- Lopinavir/Ritonavir
A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease Inhibitors
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2009-02-20
- Lead Sponsor
- Abbott
- Registration Number
- NCT00004580
- Locations
- 🇺🇸
Univ of Cincinnati Med Ctr / Holmes Div Mail Loc 0405, Cincinnati, Ohio, United States
🇺🇸Pacific Oaks Research, Beverly Hills, California, United States
🇺🇸Duke Univ Med Ctr / Infectious Disease Clinic, Durham, North Carolina, United States
A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Previously Received Anti-HIV Treatment
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2009-02-20
- Lead Sponsor
- Abbott
- Target Recruit Count
- 300
- Registration Number
- NCT00004581
- Locations
- 🇨🇦
Clinique Medicale L'Actuele, Montreal, Quebec, Canada
🇨🇦Montreal Chest Institute, Montreal, Quebec, Canada
🇺🇸Tower ID Med Associates, Los Angeles, California, United States
A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Positive Patients Without Previous Anti-HIV Drug Therapy
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2009-02-20
- Lead Sponsor
- Abbott
- Target Recruit Count
- 660
- Registration Number
- NCT00004583
- Locations
- 🇺🇸
Vanderbilt Univ Med Ctr, Nashville, Tennessee, United States
🇺🇸Univ of Miami School of Medicine, Miami, Florida, United States
🇺🇸Tower ID Med Associates, Los Angeles, California, United States
A Study of HIV-Disease Development in Aging
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-01
- Target Recruit Count
- 90
- Registration Number
- NCT00006144
- Locations
- 🇺🇸
Santa Clara Valley Med. Ctr., San Jose, California, United States
🇺🇸Mt. Sinai Med. Ctr. A0404 CRS, New York, New York, United States
🇺🇸Columbia Univ., HIV Prevention and Treatment Medical Ctr., New York, New York, United States
ABT-378/Ritonavir and Efavirenz in HIV-Infected Patients Who Have Taken More Than One Protease Inhibitor in the Past
- Conditions
- HIV Infections
- Locations
- 🇺🇸
ViRx Inc, San Francisco, California, United States
Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Triangle Pharmaceuticals
- Target Recruit Count
- 100
- Registration Number
- NCT00017992
- Locations
- 🇺🇸
USC School of Medicine / LA County Med Ctr, Los Angeles, California, United States
🇺🇸Univ of Miami, Miami, Florida, United States
🇲🇽Instituto Mexicano de Investigacion Clinica, Col Roma, Mexico
ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects
- Conditions
- HIV Infections
- Interventions
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2008-04-03
- Lead Sponsor
- Abbott
- Target Recruit Count
- 100
- Registration Number
- NCT00004578
- Locations
- 🇺🇸
Northwestern University Medical School, Chicago, Illinois, United States
🇺🇸University of Colorado Health Sciences Center, Denver, Colorado, United States
🇺🇸Baylor College of Medicine, Houston, Texas, United States
Effect of a Change in HIV Therapy on Liver Steatosis, Inflammation, and Fibrosis
- Conditions
- HIV InfectionsHepatitis C
- Locations
- 🇺🇸
Univ of Hawaii, Honolulu, Hawaii, United States
🇺🇸Beth Israel Med Ctr, New York, New York, United States
🇺🇸Tripler Army Med Ctr, Tripler AMC, Hawaii, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.